GTR Test Accession:
Help
GTR000613358.1
Registered in GTR:
2024-07-31
View version history
GTR000613358.1,
registered in GTR:
2024-07-31
Last annual review date for the lab: 2024-08-07
LinkOut
At a Glance
Test purpose:
Help
Diagnosis;
Pre-symptomatic;
Risk Assessment
Conditions (4):
Help
Tyrosinemia type I;
Agenesis of the corpus callosum with peripheral neuropathy;
Charlevoix-Saguenay spastic ataxia
more...
1061C>T (A354V) mutation of the LRPPRC gene;
1062+5G>A mutation of FAH Gene;
2436deltaG mutation of SLC12A6 gene;
6594deltaT and 5254C>T mutations of SACS gene
Methods (1):
Help
Molecular Genetics - Targeted variant analysis: Oligonucleotide hybridization-based DNA sequencing
Target population: Help
Identification of carrier status in a preconception or prenatal situation …
Clinical validity:
Help
Concerning the four SLSJ diseases, the clinical validity of carrier …
Clinical utility:
Help
Establish or confirm diagnosis;
Reproductive decision-making
Ordering Information
Offered by:
Help
Laboratoire de Diagnostic Moleculaire
View lab's test page
View lab's test page
Test short name:
Help
GSLSJ
Specimen Source:
Help
- Amniocytes
- Chorionic villi
- Isolated DNA
- Peripheral (whole) blood
- View specimen requirements
Who can order: Help
- Licensed Physician
Test Order Code:
Help
GSLSJ
View other test codes
View other test codes
LOINC codes:
Help
Lab contact:
Help
Jacqueline Dionne, BSc, Staff
jacqueline.dionne@chudequebec.ca
1-418-525-4444 ext 52426
Francois Rousseau, PhD, MD, MSc, Lab Director
francois.rousseau.med@ssss.gouv.qc.ca
1-418-525-4470
jacqueline.dionne@chudequebec.ca
1-418-525-4444 ext 52426
Francois Rousseau, PhD, MD, MSc, Lab Director
francois.rousseau.med@ssss.gouv.qc.ca
1-418-525-4470
Contact Policy:
Help
Laboratory can only accept contact from health care providers. Patients/families are encouraged to discuss genetic testing options with their health care provider.
How to Order:
Help
Blood, chorionnic villi, amniocytes, DNA are accepted
Order URL
Order URL
Test service:
Help
Clinical Testing/Confirmation of Mutations Identified Previously
OrderCode: GSLSJ
Result interpretation
OrderCode: GSLSJ
OrderCode: GSLSJ
Result interpretation
OrderCode: GSLSJ
Test development:
Help
Manufactured (research use only; not FDA-reviewed)
Informed consent required:
Help
Decline to answer
Test strategy:
Help
The five mutations of the four Saguenay-Lac-Saint-Jean diseases are tested at the same time, with a single sample (multiplex). It is also possible to test only one, two or three mutations, at the request of the doctor.
View citations (1)
- Quatre maladies récessives du Saguenay-Lac-Saint-Jean-Recherche de mutations (Référence-2014.03.02) Avis d'évaluation. INESSS Avis au ministre de la santé.
Pre-test genetic counseling required:
Help
Decline to answer
Post-test genetic counseling required:
Help
Decline to answer
Conditions
Help
Total conditions: 4
Condition/Phenotype | Identifier |
---|
Test Targets
Chromosomal regions/Mitochondria
Help
Total chromosomal regions/mitochondria: 4
Chromosomal region/Mitochondrion | Associated condition |
---|
Methodology
Total methods: 1
Method Category
Help
Test method
Help
Instrument *
Targeted variant analysis
Oligonucleotide hybridization-based DNA sequencing
* Instrument: Not provided
Clinical Information
Test purpose:
Help
Diagnosis;
Pre-symptomatic;
Risk Assessment
Clinical validity:
Help
Concerning the four SLSJ diseases, the clinical validity of carrier tests is well established because: the target population is known and homogeneous; the genes involved are known and unique; the frequency of causal alleles is known and high (see Table 2); the number of responsible mutations …
View more
View citations (1)
- Concernant les quatre maladies du SLSJ, la validité clinique des tests de porteurs est bien établie car : la population cible est connue et homogène; les gènes en cause sont connus et uniques; la fréquence des allèles causals est connue et élevée (voir le tableau 2); le nombre de mutations responsables est restreint et leur pénétrance est élevée. Quatre maladies récessives du Saguenay-Lac-Saint-Jean-Recherche de mutations (Référence-2014.03.02) Avis d'évaluation. INESSS Avis au ministre de la santé. p. 8
Clinical utility:
Help
Target population:
Help
Identification of carrier status in a preconception or prenatal situation
Prenatal diagnosis
Confirmation diagnosis
View citations (1)
- Quatre maladies récessives du Saguenay-Lac-Saint-Jean-Recherche de mutations (Référence-2014.03.02) Avis d'évaluation. INESSS Avis au ministre de la santé.
Recommended fields not provided:
What is the protocol for interpreting a variation as a VUS?,
Are family members with defined clinical status recruited to assess significance of VUS without charge?,
Will the lab re-contact the ordering physician if variant interpretation changes?,
Is research allowed on the sample after clinical testing is complete?,
Sample negative report,
Sample positive report
Technical Information
Test Procedure:
Help
SNaPshot (Applied Biosystem)
Availability:
Help
Tests performed
Entire test performed in-house
Entire test performed in-house
Analytical Validity:
Help
Analytical specificity >99%
View citations (2)
- Les codemandeurs sont désignés pour ces analyses depuis 10 ans, et un rehaussement technologique a été proposé. Le SNaPshot®4X inclut une double amplification du même locus suivie d’une détection bi-caténaire selon le principe d’extension d’amorce. L’analyse est conçue pour détecter les erreurs de génotypes documentées à la fois par les demandeurs et dans la littérature. Ils ont fourni les données de validation analytique requises. Les mesures de contrôle de qualité ont fait l’objet de procédures opératoires normalisées développées par les requérants. Les contrôles de qualité interne sont décrits.Il y a concordance complète (100 %) entre les analyses effectuées avec la nouvelle méthode et celles déjà inscrites. Selon les données fournies par les demandeurs, la technique est robuste, précise et spécifique. Le SNaPshot®4X confère donc une sensibilité analytique accrue.
- Quatre maladies récessives du Saguenay-Lac-Saint-Jean-Recherche de mutations (Référence-2014.03.02) Avis d'évaluation. INESSS Avis au ministre de la santé. p.14
Assay limitations:
Help
Detection limit: 4 nanograms of DNA
View citations (1)
- Limite de détection Quatre nanogrammes d’ADN génomique. Quatre maladies récessives du Saguenay-Lac-Saint-Jean-Recherche de mutations (Référence-2014.03.02) Avis d'évaluation. INESSS Avis au ministre de la santé. p. 9
Proficiency testing (PT):
Is proficiency testing performed for this test?
Help
Yes
Method used for proficiency testing: Help
Formal PT program
PT Provider: Help
Laboratoire de santé publique du Québec
Description of PT method: Help
Proficiency testing specimens (4) are tested twice a year with the laboratory's regular workload, using routine methods. The analytes evaluated correspond to each of the five pathogenic variants associated with four recessive hereditary diseases that are overprevalent in people from the Saguenay-Lac-Saint-Jean, Charlevoix and Haute-Côte-Nord regions.
Yes
Method used for proficiency testing: Help
Formal PT program
PT Provider: Help
Laboratoire de santé publique du Québec
Description of PT method: Help
Proficiency testing specimens (4) are tested twice a year with the laboratory's regular workload, using routine methods. The analytes evaluated correspond to each of the five pathogenic variants associated with four recessive hereditary diseases that are overprevalent in people from the Saguenay-Lac-Saint-Jean, Charlevoix and Haute-Côte-Nord regions.
Recommended fields not provided:
Test Confirmation,
Description of internal test validation method,
Major CAP category, CAP category, CAP test list
Regulatory Approval
FDA Review:
Help
Category:
FDA exercises enforcement discretion
Additional Information
Clinical resources:
Molecular resources:
Practice guidelines:
IMPORTANT NOTE:
NIH does not independently verify information submitted to GTR; it relies on submitters to provide information that is accurate and not misleading.
NIH makes no endorsements of tests or laboratories listed in GTR. GTR is not a substitute for medical advice.
Patients and consumers
with specific questions about a genetic test should contact a health care provider or a genetics professional.